---
category: legislation
date: '2021-04-23'
modified_time: 2022-03-15 11:09:02-04:00
permalink: https://www.whitehouse.gov/briefing-room/legislation/2021/04/23/bills-signed-s-164-s-415-s-422-s-578/
published_time: 2021-04-23 17:54:15-04:00
title: "Bills Signed: S. 164, S. 415, S. 422, S.\_578"
---
 
On Friday, April 23, 2021, the President signed into law:

S. 164, the “Advancing Education on Biosimilars Act of 2021,” which
authorizes the Food and Drug Administration to educate consumers and
health care providers on biologic products, including biosimilars;  

S. 415, which clarifies the definition of a new chemical entity for the
purposes of an application for approval by the Food and Drug
Administration;

S. 422, the “Senate Shared Employee Act,” which allows Senators,
Senators-elect, committees of the Senate, leadership offices, and other
offices of the Senate to share employees; and   

S. 578, the “Food Allergy Safety, Treatment, Education, and Research Act
of 2021 or the FASTER Act of 2021,” which adds sesame to the list of
major allergens for purposes of food labeling.
